Retractable Technologies (RVP) Income from Continuing Operations (2010 - 2026)
Retractable Technologies' (RVP) quarterly Income from Continuing Operations came in at 4225170.0 in Q1 2026, up 59.76% YoY from 2644648.15 in Q1 2025, and down 79.94% on a QoQ basis from 2348090.0 in Q4 2025.
Retractable Technologies (RVP) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Income from Continuing Operations data on file, last reported at 4225170.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 59.76% year-over-year to 4225170.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6289684.0 (up 72.43% YoY) and the FY2025 annual result came in at 12565230.0, down 5.71% from the prior year.
- Income from Continuing Operations eased to 4225170.0 in Q1 2026, from 2348090.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 7616455.0 in Q1 2022 to a low of 14164640.0 in Q2 2024.
- A 5-year average of 1800553.24 and a median of 1921989.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations surged 5269.2% — and 2025, when it tumbled 2545.53%.
- Tracing RVP's Income from Continuing Operations over 5 years: stood at 4281556.0 in 2022, then soared by 98.3% to 72946.0 in 2023, then surged by 5269.2% to 3770722.0 in 2024, then slumped by 162.27% to 2348090.0 in 2025, then tumbled by 79.94% to 4225170.0 in 2026.
- The last three Income from Continuing Operations figures came in at 4225170.0 (Q1 2026), 2348090.0 (Q4 2025), and 371047.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Retractable Technologies | 21.84 Mn | -18.03 Mn | 190,852.00 | 2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.23 Mn |
| Dec 31, 2025 | -2.35 Mn |
| Sep 30, 2025 | 371,047.00 |
| Jun 30, 2025 | -87,471.00 |
| Mar 31, 2025 | -10.50 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -14.16 Mn |
| Mar 31, 2024 | 429,384.00 |
| Dec 31, 2023 | -72,946.00 |
| Sep 30, 2023 | -4.06 Mn |
| Jun 30, 2023 | -3.87 Mn |
| Mar 31, 2023 | 990,972.00 |
| Dec 31, 2022 | -4.28 Mn |
| Sep 30, 2022 | 5.39 Mn |
| Jun 30, 2022 | -3.64 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 11.69 Mn |
| Sep 30, 2021 | 6.52 Mn |
| Jun 30, 2021 | 10.66 Mn |